A Randomised, Multi-Centre, Double-Blind, Placebo and Active-Controlled, 5-Way Parallel Group Study to Investigate the Efficacy, Safety and Tolerability of ONO-8539 in Patients With Overactive Bladder

Update Il y a 4 ans
Reference:

Extract


Inclusion criteria

  • N32.8 - Other specified disorders of bladder ,Overactive Bladder


Links